To continue reading this article, sign up for FREE to
Membership is FREE
and provides you with
instant access
to email newsletters, digital publications, our full content catalogue & more...
Already have an account?
Eden Biodesign Presents at PepTalk Protein Bioprocessing Conference
Read time: Less than a minute
Eden Biodesign Limited will be exhibiting at PepTalk in San Diego from January 11th to 16th 2009. PepTalk is one of the largest conferences of its kind devoted to formulating biologics, bioprocessing, antibody and protein therapeutics and protein science and technology.
In addition to exhibiting at PepTalk in San Diego, Dr David Simpson, Process Development Manager at Eden Biodesign Ltd in Liverpool will be hosting an interactive session on Tuesday January 13th on monitoring bioprocesses using Near Infra Red Spectroscopy (NIRS) techniques.
In line with the FDA’s endorsement of process analytical technology (PAT), Dr Simpson’s discussion will focus on the versatility and utility of NIRS in biotherapeutic manufacturing and its applicability in the rapid development of both bespoke and platform systems.
Specific areas for discussion will concentrate on the Eden Biodesign approach to the application of NIRS for production campaigns, maximizing early phase development, applicability to the specific variant expression systems and its use in assessing product stability.
In addition to exhibiting at PepTalk in San Diego, Dr David Simpson, Process Development Manager at Eden Biodesign Ltd in Liverpool will be hosting an interactive session on Tuesday January 13th on monitoring bioprocesses using Near Infra Red Spectroscopy (NIRS) techniques.
In line with the FDA’s endorsement of process analytical technology (PAT), Dr Simpson’s discussion will focus on the versatility and utility of NIRS in biotherapeutic manufacturing and its applicability in the rapid development of both bespoke and platform systems.
Specific areas for discussion will concentrate on the Eden Biodesign approach to the application of NIRS for production campaigns, maximizing early phase development, applicability to the specific variant expression systems and its use in assessing product stability.
Add Technology Networks as a preferred Google source to see more of our trusted coverage.
